Clinical Trial: Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Locally Advanced Rectal Carcinoma
Study Type: INTERVENTIONAL
Official Title: A Prospective, Open-Label, Single-Arm and Multicentre Phase II Study to Explore the Efficacy and Safety of Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Middle and L
Brief Summary:
The goal of this clinical trial is to test the efficacy and safety in patients with locally advanced middle and lower rectal cancer.The main questions it aims to answer are:• Whether Cadonilimab combined with chemotherapy following short-course radiation can improve pathological complete response(pCR) rate?•Are the toxicities of the combination therapy manageable?Participants will be given radiation of 5 Gy for 5 days and then neoadjuvant Cadonilimab combined with modified fluorouracil, leucovorin, and oxaliplatin…
Read more